UnitedHealth Group Optum Rx — Segment, Expenditure, Addition to Long-Lived Assets remained flat by 0.0% to $104.75M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $86.75M to $104.75M. Over 3 years (FY 2021 to FY 2024), Optum Rx — Segment, Expenditure, Addition to Long-Lived Assets shows an upward trend with a 11.7% CAGR.
Higher investment indicates a focus on modernization and capacity expansion, while lower investment may signal a focus on cash flow optimization.
The capital expenditure invested in property, equipment, technology, and other long-term assets to support the pharmacy...
Equivalent to 'Capital Expenditures' or 'Additions to Property, Plant, and Equipment' reported at the segment level.
unh_segment_optum_rx_segment_expenditure_addition_to_long_lived_assets| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $301.00M | $308.00M | $347.00M | $419.00M |
| YoY Change | — | +2.3% | +12.7% | +20.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.